University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Online Study of the Effects of Sugary Drink Warning Labels on Consumption

Not Applicable

Completed

Conditions: Food Preferences

Interventions: Behavioral: Exposure to calorie information
Behavioral: Exposure to sugar-sweetened beverage warning labels

First Posted Date: 2021-10-15

Last Posted Date: 2024-04-04

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 216

Registration Number: NCT05079477

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

The Effects of IQOS Use on Cigarette Smoking Behaviors

Early Phase 1

Active, not recruiting

Conditions: Cigarette Smoking
Tobacco Use
Smoking

Interventions: Other: IQOS

First Posted Date: 2021-10-13

Last Posted Date: 2024-03-06

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 101

Registration Number: NCT05076708

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

The STEP 4Life Trial

Not Applicable

Completed

Conditions: Alzheimer Disease, Protection Against
Alzheimer Disease, At Risk
Dementia

Interventions: Behavioral: Gamification

First Posted Date: 2021-10-06

Last Posted Date: 2023-11-28

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 240

Registration Number: NCT05069155

Locations: 🇺🇸
Blockley Hall, Philadelphia, Pennsylvania, United States

Mixed Presentation on Social Media

Not Applicable

Completed

Conditions: Tobacco Use
Tobacco Dependence

Interventions: Behavioral: Mixed-Presentation of Content

First Posted Date: 2021-10-04

Last Posted Date: 2022-10-28

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 828

Registration Number: NCT05066126

Locations: 🇺🇸
Annenberg School for Communication, Philadelphia, Pennsylvania, United States

The Digital Wellbeing Project

Not Applicable

Completed

Conditions: Mental Health

Interventions: Behavioral: immi
Behavioral: Control

First Posted Date: 2021-09-30

Last Posted Date: 2023-06-05

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 270

Registration Number: NCT05061966

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Heart Smart: A Virtual Self-Management Program for Homebound People With Heart Failure

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Other: Heart Smart Virtual Self-Management Group

First Posted Date: 2021-09-27

Last Posted Date: 2022-03-09

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 5

Registration Number: NCT05057364

Locations: 🇺🇸
Penn Medicine at Home, Bala-Cynwyd, Pennsylvania, United States

huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer

Phase 1

Active, not recruiting

Conditions: Pancreatic Cancer
Serous Ovarian Cancer

Interventions: Biological: VCN-01
Biological: huCART-meso Cells

First Posted Date: 2021-09-27

Last Posted Date: 2024-11-27

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 13

Registration Number: NCT05057715

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Penn SICCA Follow-up Study

Not yet recruiting

Conditions: Sjogren's Syndrome
Dry Eye

First Posted Date: 2021-09-24

Last Posted Date: 2024-10-21

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 220

Registration Number: NCT05056012

Locations: 🇺🇸
Scheie Eye Institute, Philadelphia, Pennsylvania, United States

DISE: Phenotyping Obstruction Patterns

Not Applicable

Recruiting

Conditions: Obstructive Sleep Apnea

Interventions: Other: Pharyngeal Manometry
Other: Submental Ultrasound

First Posted Date: 2021-09-20

Last Posted Date: 2024-05-31

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 241

Registration Number: NCT05050383

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and Lymphoma

Phase 1

Withdrawn

Conditions: Non Hodgkin Lymphoma
Acute Lymphoblastic Leukemia
Chronic Lymphocytic Leukemia

Interventions: Biological: PACE CART19

First Posted Date: 2021-09-08

Last Posted Date: 2023-06-22

Lead Sponsor: University of Pennsylvania

Registration Number: NCT05037669

Home Terms & Conditions Privacy Policy